TidalSense

Cambridge-based health tech startup TidalSense has successfully raised £14.2 million (equivalent to $19 million) in a recent funding round. This capital injection is earmarked to accelerate the commercial expansion of its innovative AI-powered respiratory diagnostic device, N-Tidal Diagnose, and to prepare for entry into the US market.

Summary of transaction details:

• Value: £14.2 million ($19 million)
• Sector: Healthcare & Biotech (AI Diagnostics)
• Advisor: Not mentioned
• Key Entities: TidalSense (Target), Cross-Border Impact Ventures (Lead Investor), BGF, Airstream Capital, Foresight Group (Returning Backers)
• Location: Cambridge, UK (Target)

Note: This funding round highlights a strategic investment in advanced AI diagnostics to address significant gaps in respiratory disease diagnosis. By supporting TidalSense's expansion, investors aim to improve access to accurate, rapid diagnostic tools for conditions like COPD globally, particularly benefiting underserved communities.